(-0.22%) 5 011.12 points
(0.06%) 37 775 points
(-0.52%) 15 601 points
(3.30%) $85.46
(1.20%) $1.778
(0.56%) $2 411.50
(0.67%) $28.57
(0.14%) $955.80
(0.20%) $0.941
(0.17%) $11.06
(0.27%) $0.806
(0.05%) $93.95
Live Chart Being Loaded With Signals
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases...
Stats | |
---|---|
Today's Volume | 23.92M |
Average Volume | 0.00 |
Market Cap | 26.63B |
EPS | $1.250 ( 2023-11-01 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 61.86 |
ATR14 | $0.803 (0.69%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-06 | Watkins Thomas | Sell | 10 000 | Ordinary Shares |
2023-10-06 | Watkins Thomas | Sell | 8 548 | Stock Option (Right to Buy) |
2023-10-06 | Watkins Thomas | Sell | 23 092 | Stock Option (Right to Buy) |
2023-10-06 | Watkins Thomas | Sell | 31 153 | Stock Option (Right to Buy) |
2023-10-06 | Watkins Thomas | Sell | 10 838 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-89.04 |
Last 100 transactions |
Buy: 244 079 | Sell: 3 988 089 |
Volume Correlation
Horizon Therapeutics PLC Correlation
10 Most Positive Correlations | |
---|---|
BOCH | 0.96 |
NWFL | 0.955 |
WLFC | 0.945 |
PPH | 0.944 |
SNY | 0.943 |
DVCR | 0.941 |
SHSP | 0.94 |
ROST | 0.938 |
MGI | 0.937 |
EWEB | 0.937 |
10 Most Negative Correlations | |
---|---|
GAINL | -0.964 |
QTEK | -0.96 |
FATE | -0.959 |
LNSR | -0.957 |
IMCC | -0.953 |
VS | -0.95 |
QLGN | -0.949 |
WISA | -0.947 |
TOPS | -0.945 |
LHDX | -0.945 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Horizon Therapeutics PLC Correlation - Currency/Commodity
Horizon Therapeutics PLC Financials
Annual | 2022 |
Revenue: | $3.63B |
Gross Profit: | $2.71B (74.64 %) |
EPS: | $2.28 |
Q2 | 2023 |
Revenue: | $944.96M |
Gross Profit: | $725.00M (76.72 %) |
EPS: | $0.560 |
Q1 | 2023 |
Revenue: | $832.06M |
Gross Profit: | $623.50M (74.93 %) |
EPS: | $0.240 |
Q4 | 2022 |
Revenue: | $942.03M |
Gross Profit: | $701.24M (74.44 %) |
EPS: | $0.530 |
Financial Reports:
No articles found.
Horizon Therapeutics PLC
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC.; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; and Arrowhead Pharmaceuticals, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois; Chicago, Illinois; Lake Forest, Illinois; South San Francisco, California; Washington, D.C.; Gaithersburg, Maryland; Rockville, Maryland; and Mannheim, Germany.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators